Accreditation

Continuing Medical Education Information

 

Target Audience

Endocrinologists, cardiologists, nephrologists, gastroenterologists/liver disease specialists, physician assistants, nurse practitioners, nurses, and primary care physicians.

 

Learning Objective

By the end of the meeting, participants will be able to:

  • Utilize the latest clinical practice guidelines on cardiometabolic disease, including type 2 diabetes (T2D) and cardiovascular risk/heart failure, obesity, and chronic kidney disease.
  • Summarize key characteristics of evidence-based assessment and treatment options for patients at risk or with cardiometabolic disease.
  • Discuss barriers in being able to manage the risk factors as well as the ability of patients to carry through recommendations for a healthier lifestyle.
  • Update cardiovascular risk management approaches that remain controversial without consensus as to best approach.

 

Accreditation and Designation Statements

ACCME
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this “Other” for a maximum of 12.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).

Joint Accreditation Statement
PIM logo In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 12.5 contact hours.
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 12.5 contact hours.

Continuing Physician Assistant Education
AAPA logo Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

 

Disclosure and Conflicts of Interest Policy:

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities

Commercial Support
This activity is supported by independent educational grants from:

  • Novo Nordisk, Inc.
  • Pfizer-Merck Alliance
  • Medtronic
  • Pfizer

Partnering Organizations

  • American Association for the Study of Liver Diseases (AASLD)
  • National Kidney Foundation (NKF)
  • Preventive Cardiovascular Nurses Association (PCNA)
  • American Society of Preventive Cardiology (ASPC)
  • Endocrine Nurses Society (ENS)

Planning Committee

  • Dr. Dace Trence, MD, MACE (Program Chair)
  • Dr. Archana Sadhu, MD, FACE
  • Dr. Scott Isaacs, MD
  • Dr. Armand Krikorian, MD, FACE, MBA, FACP
  • Dr. Monica Agarwal, MD, MEHP, FACE
  • Dr. David Lieb, MD

Faculty

Individual with Disclosed Financial Relationship Name of Commercial Interest Disclosed Nature of Relationship with the Commercial Interest
Monica Agarwal, MD, MEHP, FACE Nothing to disclose N/A
Lissa Bauer, MD Nothing to disclose N/A
Jackie Boucher, MS, RDN Nothing to disclose N/A
Stacy Brethauer, MD Nothing to disclose N/A
Felice Caldarella, MD, FACP, CDCES, FACE, MBA Nothing to disclose N/A
Joumana Chaiban, MD, MBA, FACE Nothing to disclose N/A
Ricardo Correa, MD, EdD Nothing to disclose N/A
Leslie Eldeiry, MD Nothing to disclose N/A
Charles Farmer, MD Nothing to disclose N/A
Benjamin Gigliotti, MD Nothing to disclose N/A
Michael Irwig, MD Nothing to disclose N/A
Kenneth Izuora, MD, MBA, FACE Nothing to disclose N/A
Rosemarie Lajara, MD Nothing to disclose N/A
Howard Lando, MD, FACP, FACE Nothing to disclose N/A
David Lieb, MD, FACP, FACE Nothing to disclose N/A
Gina Lundberg, MD Nothing to disclose N/A
Jovan Milosavljevic, MD Nothing to disclose N/A
Karl Nadolsky, DO, FACE Nothing to disclose N/A
Sethu Reddy, MD, MBA Nothing to disclose N/A
Daniel Roe, MPAcc Nothing to disclose N/A
Cheryl Rosenfeld, DO Nothing to disclose N/A
Archana Sadhu, MD, FACE Nothing to disclose N/A
Jad Sfeir, MD, FACP Nothing to disclose N/A
C. Leslie Smith, MS, MA, LAc, MD, FABMA, Dipl NCCAOM Nothing to disclose N/A
Manoj Kumar Somagutta, MD Nothing to disclose N/A
Reshmi Srinath, MD Nothing to disclose N/A
Vin Tangpricha, MD, PhD Nothing to disclose N/A
Anh Tran, DO Nothing to disclose N/A
Dace Trence, MD, MACE Nothing to disclose N/A
Guillermo E. Umpierrez, MD, FACP, CDCES, FACE Nothing to disclose N/A
Melanie Westfall, FNP-C Nothing to disclose N/A
Kittie Wyne, MD, PhD, FACE Nothing to disclose N/A
Christine Yedinak, DNP Nothing to disclose N/A
Zobair Younossi, MD Nothing to disclose N/A
Polina Zykova Nothing to disclose N/A
Manal F. Abdelmalek, MD, MPH 89 Bio Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Bayer Honorarium, Boehringer Ingelheim (Self), Consulting Fees (e.g., advisory boards)
  Boehringer Ingelheim University Grants/Research Support
  Bristol Myers Squibb Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Celgene University Grants/Research Support
  Galmed Pharmaceuticals University Grants/Research Support
  Genentech University Grants/Research Support
  Hanmi Pharmaceuticals Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Intercept Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Inventiva Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Madrigal Consulting Fees (e.g., advisory boards), University Grants/Research Support
  NGM Biopharmaceuticals Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Novartis Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Novo Nordisk Consulting Fees (e.g., advisory boards), University Grants/Research Support
  Poxel University Grants/Research Support
  SonoIncytes Consulting Fees (e.g., advisory boards)
  Theratherapeutic Consulting Fees (e.g., advisory boards)
  Viking University Grants/Research Support
Naim Alkhouri, MD Fibronostics Consulting Fees (e.g., advisory boards), Grant/Research Support
  Gilead Consulting Fees (e.g., advisory boards), Grant/Research Support, Honorarium
  Intercept Consulting Fees (e.g., advisory boards), Grant/Research Support, Honorarium
  Inventiva Consulting Fees (e.g., advisory boards), Grant/Research Support
  Madrigal Consulting Fees (e.g., advisory boards), Grant/Research Support
  Novo Nordisk Consulting Fees (e.g., advisory boards), Grant/Research Support
Irina Bancos, MD Corcept Consulting Fees (e.g., advisory boards), Grant/Research Support
  Sparrow Pharmaceutics Consulting Fees (e.g., advisory boards)
Eliot A. Brinton, MD 89bio Consulting Fees (e.g., advisory boards)
  Amarin Honorarium, Research Support
  Amgen Honorarium
  Amryt Honorarium
  Dalcor Consulting Fees (e.g., advisory boards)
  Esperion Honorarium
  Kowa Grant/Research Support
  Merck Consulting Fees (e.g., advisory boards)
  Novartis Consulting Fees (e.g., advisory boards)
  Pfizer Consulting Fees (e.g., advisory boards)
  Regeneron Research Grant
Elena Christofides, MD, FACE Abbott/AbbVie Consulting Fees (e.g., advisory boards), Contracted Research, Honorarium
  Amgen Contracted Research
  Bayer Consulting Fees (e.g., advisory boards)
  Boehringer Ingelheim Consulting Fees (e.g., advisory boards), Honorarium
  Eli Lilly Consulting Fees (e.g., advisory boards), Honorarium
  Novo Nordisk Honorarium
W. Timothy Garvey, MD, MACE Eli Lilly site PI of clinical trial sponsored by University of Alabama at Birmingham and funded by Eli Lilly, University Grants/Research Support
  Epitomee site PI of clinical trial sponsored by University of Alabama at Birmingham and funded by Eli Lilly, University Grants/Research Support
  Novo Nordisk site PI of clinical trial sponsored by University of Alabama at Birmingham and funded by Eli Lilly, University Grants/Research Support
  Pfizer site PI of clinical trial sponsored by University of Alabama at Birmingham and funded by Eli Lilly, University Grants/Research Support
Scott Isaacs, MD Quest Consulting Fees (e.g., advisory boards)
Armand Krikorian, MD, FACE, MBA, FACP Doximity Ownership Interest
Janet B. McGill, MD, FACE Bayer Consulting Fees (e.g., advisory boards)
  Beta Bionics University Grants/Research Support
  Dexcom University Grants/Research Support
  Medtronic University Grants/Research Support
  Novo Nordisk University Grants/Research Support
Jessica Mahoney, MD Pause and Presence, LLC Owner of Pause & Presence LLC, a company that offers physician coaching, Stockholder/Ownership Interest (excluding diversified mutual funds)
Jeffrey I. Mechanick, MD Abbott Nutritional International Honoraria for lectures, Honorarium
  GoodSugar+ Ownership Interest - 5% ownership; no valuation of company (no income yet) (GoodSugar+ is a restaurant)
E.J. Milas, NP, DNP Indorsia Pharmaceuticals Salary
Ann Marie Navar, MD Amarin, Amgen, AstraZeneca, BI, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, Novo Nordisk, Novartis, The Medicines Company, New Amsterdam, Cerner, 89Bio, Pfizer Consulting Fees (e.g., advisory boards)
  Amgen, BMS, Esperion, and Janssen Grant/Research Support
Genevieve Neal-Perry, MD, PhD Astellas Consulting Fees (e.g., advisory boards)
  Organon Research Grant
Monica Peek, MD, MPH, MS, FACP Merck Foundation Grant/Research Support, Research Grant
  NIH/NIDDK P30 DK092949 Grant/Research Support, Research Grant
Rachel Pessah-Pollack, MD, FACE Boehringer Ingelheim/Eli Lilly Consulting Fees (e.g., advisory boards), Honorarium
  Health Monitor Honorarium
Mary Rinella, MD Alnylam, Amgen, AMRA, BMS, Boehringer Ingelheim, Centara, Coherus, Enanta, Galecto, Intercept Pharmaceuticals, Madrigal, NGM Biopharmaceuticals, Novo Nordisk, Pfizer, Fractyl, Gelesis, Siemens, Thetis, Terns, Rivus, 3vBio (Sagimet), 89Bio and Novartis Consulting; all contracts cancelled as of 2021
Katherine R. Tuttle, MD, FASN, FACP, FNKF AstraZeneca Consulting Fees (e.g., advisory boards), Honorarium
  Bayer Honorarium, Boehringer Ingelheim (Self), Consulting Fees (e.g., advisory boards)
  Boehringer Ingelheim Consulting Fees (e.g., advisory boards), Honorarium
  Gilead Consulting Fees (e.g., advisory boards), Honorarium
  Goldfinch Bio Consulting Fees (e.g., advisory boards), Grant/Research Support, Honorarium, Research Grant
  Novo Nordisk Consulting Fees (e.g., advisory boards)
Guillermo Umpierrez, MD, FACE, FACP, CDCES Novo Nordisk, AstraZeneca, Dexcom Emory University Research Grant
Sandra Weber, MD, FACP, FACE NIH Research Grant
  Novo Nordisk Research Grant